QUINAPRIL HYDROCHLORIDE

N/A

Manufactured by Aurobindo Pharma Limited

21,985 FDA adverse event reports analyzed

Last updated: 2026-04-14

About QUINAPRIL HYDROCHLORIDE

QUINAPRIL HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Aurobindo Pharma Limited. The most commonly reported adverse reactions for QUINAPRIL HYDROCHLORIDE include FALL, PAIN, HYPOTENSION, CONSTIPATION, BALANCE DISORDER. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for QUINAPRIL HYDROCHLORIDE.

Top Adverse Reactions

FALL896 reports
PAIN752 reports
HYPOTENSION712 reports
CONSTIPATION707 reports
BALANCE DISORDER638 reports
COGNITIVE DISORDER628 reports
ORTHOSTATIC HYPOTENSION617 reports
SEDATION573 reports
MOBILITY DECREASED540 reports
DEPRESSED LEVEL OF CONSCIOUSNESS532 reports
SEDATION COMPLICATION532 reports
TOXICITY TO VARIOUS AGENTS525 reports
BLOOD CALCIUM DECREASED520 reports
CREATININE RENAL CLEARANCE DECREASED512 reports
DRUG INEFFECTIVE510 reports
DYSPNOEA502 reports
NAUSEA446 reports
DIARRHOEA374 reports
FATIGUE370 reports
DIZZINESS289 reports
ASTHENIA280 reports
MALAISE269 reports
WEIGHT DECREASED256 reports
OFF LABEL USE249 reports
COUGH240 reports
HEADACHE239 reports
VOMITING238 reports
PAIN IN EXTREMITY216 reports
BLOOD GLUCOSE INCREASED211 reports
DEATH207 reports
ARTHRALGIA205 reports
NO ADVERSE EVENT205 reports
RECALLED PRODUCT ADMINISTERED205 reports
DRUG INTERACTION193 reports
PRURITUS192 reports
PYREXIA191 reports
CHEST PAIN190 reports
INSOMNIA189 reports
BLOOD PRESSURE INCREASED184 reports
ACUTE KIDNEY INJURY180 reports
CHRONIC KIDNEY DISEASE171 reports
PNEUMONIA171 reports
HYPERTENSION161 reports
RASH156 reports
RENAL FAILURE151 reports
NASOPHARYNGITIS145 reports
BACK PAIN143 reports
ANXIETY132 reports
FEELING ABNORMAL132 reports
INFLUENZA125 reports
MYOCARDIAL INFARCTION120 reports
CONDITION AGGRAVATED119 reports
CARDIAC FAILURE CONGESTIVE117 reports
OEDEMA PERIPHERAL117 reports
CHEST DISCOMFORT116 reports
DEPRESSION116 reports
PRODUCT USE IN UNAPPROVED INDICATION115 reports
PRODUCTIVE COUGH115 reports
GAIT DISTURBANCE114 reports
DRUG HYPERSENSITIVITY113 reports
ASTHMA112 reports
ABDOMINAL DISCOMFORT111 reports
MUSCLE SPASMS111 reports
CEREBROVASCULAR ACCIDENT109 reports
FLUSHING109 reports
DECREASED APPETITE108 reports
INJURY108 reports
SYNCOPE108 reports
URTICARIA105 reports
WHEEZING105 reports
DYSPNOEA EXERTIONAL103 reports
HAEMOGLOBIN DECREASED102 reports
ATRIAL FIBRILLATION101 reports
ANAEMIA100 reports
MYALGIA100 reports
SOMNOLENCE100 reports
WEIGHT INCREASED100 reports
HYPOAESTHESIA99 reports
CONFUSIONAL STATE98 reports
GASTROINTESTINAL HAEMORRHAGE97 reports
ABDOMINAL PAIN UPPER95 reports
NASAL CONGESTION95 reports
STRESS95 reports
DEHYDRATION93 reports
PERIPHERAL SWELLING93 reports
ABDOMINAL PAIN91 reports
ANGINA PECTORIS91 reports
OVERDOSE89 reports
ALOPECIA87 reports
MUSCULAR WEAKNESS87 reports
ERYTHEMA86 reports
RHINORRHOEA86 reports
UPPER RESPIRATORY TRACT INFECTION86 reports
INJECTION SITE PAIN85 reports
LOWER RESPIRATORY TRACT INFECTION85 reports
GASTROOESOPHAGEAL REFLUX DISEASE84 reports
JOINT SWELLING78 reports
RENAL FAILURE ACUTE78 reports
CATARACT76 reports
DRUG DOSE OMISSION76 reports

Report Outcomes

Out of 7,813 classified reports for QUINAPRIL HYDROCHLORIDE:

Serious 64.0%Non-Serious 36.0%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female4,012 (55.9%)
Male3,151 (43.9%)
Unknown9 (0.1%)

Reports by Age

Age 77665 reports
Age 73192 reports
Age 61175 reports
Age 69168 reports
Age 71168 reports
Age 62156 reports
Age 68150 reports
Age 65149 reports
Age 59147 reports
Age 74147 reports
Age 63146 reports
Age 70141 reports
Age 64138 reports
Age 72137 reports
Age 67132 reports
Age 60130 reports
Age 76130 reports
Age 66117 reports
Age 58115 reports
Age 75114 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with QUINAPRIL HYDROCHLORIDE?

This profile reflects 21,985 FDA FAERS reports that mention QUINAPRIL HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for QUINAPRIL HYDROCHLORIDE?

Frequently reported terms in FAERS include FALL, PAIN, HYPOTENSION, CONSTIPATION, BALANCE DISORDER, COGNITIVE DISORDER. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures QUINAPRIL HYDROCHLORIDE?

Labeling and FAERS entries often list Aurobindo Pharma Limited in connection with QUINAPRIL HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.